Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy
US10232058B2 · kind B2 · utility
5Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2014 |
| Grant date | Mar 19, 2019 |
| Priority date | — |
| Expiry date | Dec 25, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Urea-based photosensitizers, which target prostate-specific membrane antigen (PSMA) for imaging and targeted therapy of PSMA-expressing tumors and cancers are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.